Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Prognostic Value of Minimal Residual Disease Measured By Flow Cytometry in Two Cohorts of Infants with Acute Lymphoblastic Leukemia Treated with MLL-Baby and Interfant Protocols in Large Multicenter Networks

Blood (2019) 134 (Supplement_1): 2747.

https://doi.org/10.1182/blood-2019-130210

Published: 2019

Journal Articles

Relapse Prediction By Flow Cytometric Minimal Residual Disease Assessment in Infants with Acute Lymphoblastic Leukemia

Alexander Popov, MD PhD, Tatiana Verzhbitskaya, Grigory Tsaur, MD PhD, Egor Shorikov, MD PhD, Liudmila Movchan, MD PhD, Mikhail Belevtsev, MD PhD, Anatoly Kustanovich, PhD, Olga Streneva, MD PhD, Olga Khlebnikova, MD, Natalia Myakova, Dmitry Litvinov, MD PhD, Konstantin Kondratchik, MD, Elmira Boychenko, MD PhD, Olga Aleinikova, PhD, Michael Maschan, MD PhD, Alexander Karachunskiy, MD PhD, Larisa Fechina, MD PhD

Blood (2016) 128 (22): 1731.

https://doi.org/10.1182/blood.V128.22.1731.1731

Published: 2016

Journal Articles

Detection of Translocation t(7;12)(q36;p13) in Infants with Acute Myeloid Leukemia By Novel 3-Color Fluorescent in Situ Hybridization Approach

Grigory Tsaur, MDPhD, Olga Plekhanova, Elena Fleischman, MD PhD, Elena Volochnik, Olga Sokova, PhD, Anatoly Kustanovich, PhD, Irina Kalinina, MD PhD, Alexander Popov, MDPhD, Leonid Saveliev, MD PhD, Egor Shorikov, MD PhD, Larisa Fechina, MD PhD

Blood (2015) 126 (23): 3827.

https://doi.org/10.1182/blood.V126.23.3827.3827

Published: 2015

Journal Articles

Presence of MLL Gene Rearrangements in Infant Acute Leukemia Could be Predicted By Tumor cells’ Immunophenotype

Alexander Popov, MD PhD, Grigory Tsaur, MD PhD, Tatiana Verzhbitskaya, MD PhD, Olga Streneva, MD PhD, Egor Shorikov, MD PhD, Leonid Saveliev, MD PhD, Larisa Fechina, MD PhD

Blood (2014) 124 (21): 5359.

https://doi.org/10.1182/blood.V124.21.5359.5359

Published: 2014

Journal Articles

Concordance and Prognostic Significance of Minimal Residual Disease Detection in Peripheral Blood and Bone Marrow Samples of Infants with MLL- rearranged Acute Lymphoblastic Leukemia Treated By MLL-Baby Protocol

Grigory Tsaur, MD PhD, Alexander Popov, MD PhD, Tatyana Riger, MD, Alexander Solodovnikov, MD PhD, Tatyana Nasedkina, PhD, Anatoly Kustanovich, PhD, Sergey Tsvirenko, Prof, Olga Streneva, MD PhD, Egor Shorikov, MD PhD, Leonid Saveliev, MD PhD, Larisa Fechina, MD PhD

Blood (2014) 124 (21): 2404.

https://doi.org/10.1182/blood.V124.21.2404.2404

Published: 2014

Journal Articles

Immunological Shift On Day 15 of Remission Induction in Children with CD10-Positive B-Cell Precursor ALL Treated by ALL-MB 2008 Protocol.

Alexander Popov, MD, Tatiana Verzhbitskaya, MD, PhD, Grigory Tsaur, MD, PhD, Egor Shorikov, MD, PhD, Leonid Saveliev, MD, PhD, Larisa Fechina, MD, PhD

Blood (2009) 114 (22): 2650.

https://doi.org/10.1182/blood.V114.22.2650.2650

Published: 2009

Journal Articles

WT1 Gene Expression Limited Application for MRD Monitoring in AML Patients Carrying MLL Rearrangements.

Grigory Tsaur, MD, PhD, Alexander Popov, MD, PhD, fellow, Alexander Druy, Anna Ivanova, Tatyana Riger, MD, Olga Plekhanova, Yulia Svechnikova, MD, Egor Shorikov, MD, PhD, Claus Meyer, Rolf Marschalek, Leonid Saveliev, MD, PhD, Larisa Fechina, MD, PhD

Blood (2009) 114 (22): 4700.

https://doi.org/10.1182/blood.V114.22.4700.4700

Published: 2009

Journal Articles

MRD Monitoring in AML Patients with MLL-MLLT4 by Quantification of Fusion Gene Transcripts and Genomic Chromosomal Breakpoint Sequences

Grigory Tsaur, MD, PhD, Anna Ivanova, Olga Plekhanova, Tatyana Riger, MD, Yulia Yakovleva, MD, Alexander Popov, PhD, Yulia Svechnikova, MD, Olga Makarova, MD, Egor Shorikov, MD, PhD, Leonid Saveliev, MD, PhD, Claus Meyer, PhD, Rolf Marschalek, Larisa Fechina, MD, PhD

Blood (2008) 112 (11): 4888.

https://doi.org/10.1182/blood.V112.11.4888.4888

Published: 2008

Journal Articles

Molecular Remission in MLL/AF4-Positive Infant Leukemia Treated with the All Trans-Retinoic Acid Based MLL-Baby Protocol.

Grigory Tsaur, MD, PhD, Elizaveta Semenikhina, Anna Ivanova, Tatiana Nasedkina, PhD, Alexander Popov, Egor Shorikov, MD, PhD, Leonid Saveliev, MD, PhD, Larisa Fechina, MD, PhD

Blood (2007) 110 (11): 4254.

https://doi.org/10.1182/blood.V110.11.4254.4254

Published: 2007

NARROW

Prognostic Value of Minimal Residual Disease Measured By Flow Cytometry in Two Cohorts of Infants with Acute Lymphoblastic Leukemia Treated with MLL-Baby and Interfant Protocols in Large Multicenter Networks

Relapse Prediction By Flow Cytometric Minimal Residual Disease Assessment in Infants with Acute Lymphoblastic Leukemia

Detection of Translocation t(7;12)(q36;p13) in Infants with Acute Myeloid Leukemia By Novel 3-Color Fluorescent in Situ Hybridization Approach

Presence of MLL Gene Rearrangements in Infant Acute Leukemia Could be Predicted By Tumor cells’ Immunophenotype

Concordance and Prognostic Significance of Minimal Residual Disease Detection in Peripheral Blood and Bone Marrow Samples of Infants with MLL- rearranged Acute Lymphoblastic Leukemia Treated By MLL-Baby Protocol

Immunological Shift On Day 15 of Remission Induction in Children with CD10-Positive B-Cell Precursor ALL Treated by ALL-MB 2008 Protocol.

WT1 Gene Expression Limited Application for MRD Monitoring in AML Patients Carrying MLL Rearrangements.

MRD Monitoring in AML Patients with MLL-MLLT4 by Quantification of Fusion Gene Transcripts and Genomic Chromosomal Breakpoint Sequences

Molecular Remission in MLL/AF4-Positive Infant Leukemia Treated with the All Trans-Retinoic Acid Based MLL-Baby Protocol.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only